Establishment of a second-generation transgenic marmoset model of polyglutamine disease recapitulating neurological symptoms and pathology
Eiko Nakano Minakawa, Kensuke Owari, Naotake Nogami…·Kazuhiko Seki
This paper describes a second-generation transgenic marmoset model of SCA3 that replicates motor impairments and neuropathology, offering a platform for studying disease mechanisms and therapies.